RAK-PRIDE: Optimizing Proton Pump Inhibitor Use Through Education and Intervention
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRAK Medical and Health Sciences University
About this trial
The goal of this study is to determine if a pharmacist-led educational intervention can reduce the inappropriate use of proton pump inhibitors (PPIs) among adult patients (≥18 years) with potentially inappropriate PPI prescriptions in Ras Al Khaimah.
The main questions it aims to answer are:
* Can a pharmacist-led education program reduce unnecessary PPI use? * Does the intervention improve patients' quality of life and reduce healthcare costs? Researchers will compare the intervention group (receiving pharmacist-led education and materials) to the usual care group to see if the intervention reduces PPI use and improves patient outcomes.
Participants will:
* Receive educational materials from pharmacists, including a patient educational brochure, PPI patient decision aid, PPI deprescribing pamphlet, and PPI patient action plan. * Physicians involved will also receive a pharmaceutical intervention, which includes a physician educational brochure, PPI evidence-based deprescribing guideline, PPI deprescribing algorithm, and whiteboard videos on PPI deprescribing. * Patients will be followed up for 6 months to monitor changes in PPI use, symptoms, and quality of life.
Eligibility criteria
Qualifiers
They are prescribing PPIs in outpatient department of the study sites
They have patients with potentially inappropriate PPI prescriptions
They are ≥18 years
They are presenting to out-patient departments of the study sites
Disqualifiers
They are unable to give informed consent, as judged by their physicians
They have definitive indications for PPI use
Trial design
Treatments tested in this trial
- Control (Standard treatment)
- Pharmacist-Led Educational Intervention
Treatment groups
479 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov